Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers
- PMID: 33214163
- DOI: 10.1136/gutjnl-2020-322880
Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers
Abstract
Artificial intelligence (AI) can extract complex information from visual data. Histopathology images of gastrointestinal (GI) and liver cancer contain a very high amount of information which human observers can only partially make sense of. Complementing human observers, AI allows an in-depth analysis of digitised histological slides of GI and liver cancer and offers a wide range of clinically relevant applications. First, AI can automatically detect tumour tissue, easing the exponentially increasing workload on pathologists. In addition, and possibly exceeding pathologist's capacities, AI can capture prognostically relevant tissue features and thus predict clinical outcome across GI and liver cancer types. Finally, AI has demonstrated its capacity to infer molecular and genetic alterations of cancer tissues from histological digital slides. These are likely only the first of many AI applications that will have important clinical implications. Thus, pathologists and clinicians alike should be aware of the principles of AI-based pathology and its ability to solve clinically relevant problems, along with its limitations and biases.
Keywords: cancer; computerised image analysis; histopathology.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: JC receives consulting fees from Owkin (New York, New York, USA) and Crosscope (San Francisco, California, USA). JNK has an informal, unpaid advisory role at Pathomix (Heidelberg, Germany) which does not relate to this research.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical